[1]
McCormack T, Krause T, O'Flynn N. Management of hypertension in adults in primary care: NICE guideline. The British journal of general practice : the journal of the Royal College of General Practitioners. 2012 Mar:62(596):163-4. doi: 10.3399/bjgp12X630232. Epub
[PubMed PMID: 22429432]
[2]
Fares H, DiNicolantonio JJ, O'Keefe JH, Lavie CJ. Amlodipine in hypertension: a first-line agent with efficacy for improving blood pressure and patient outcomes. Open heart. 2016:3(2):e000473
[PubMed PMID: 27752334]
[3]
Ferrari R, Pavasini R, Camici PG, Crea F, Danchin N, Pinto F, Manolis A, Marzilli M, Rosano GMC, Lopez-Sendon J, Fox K. Anti-anginal drugs-beliefs and evidence: systematic review covering 50 years of medical treatment. European heart journal. 2019 Jan 7:40(2):190-194. doi: 10.1093/eurheartj/ehy504. Epub
[PubMed PMID: 30165445]
Level 1 (high-level) evidence
[4]
Fihn SD, Gardin JM, Abrams J, Berra K, Blankenship JC, Dallas AP, Douglas PS, Foody JM, Gerber TC, Hinderliter AL, King SB 3rd, Kligfield PD, Krumholz HM, Kwong RY, Lim MJ, Linderbaum JA, Mack MJ, Munger MA, Prager RL, Sabik JF, Shaw LJ, Sikkema JD, Smith CR Jr, Smith SC Jr, Spertus JA, Williams SV, Anderson JL, American College of Cardiology Foundation/American Heart Association Task Force. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation. 2012 Dec 18:126(25):e354-471. doi: 10.1161/CIR.0b013e318277d6a0. Epub 2012 Nov 19
[PubMed PMID: 23166211]
Level 1 (high-level) evidence
[5]
Pitt B, Byington RP, Furberg CD, Hunninghake DB, Mancini GB, Miller ME, Riley W. Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. PREVENT Investigators. Circulation. 2000 Sep 26:102(13):1503-10
[PubMed PMID: 11004140]
[6]
Tabur S, Oğuz E, Sabuncu T, Korkmaz H, Çelik H. The effects of calcium channel blockers on nephropathy and pigment epithelium-derived factor in the treatment of hypertensive patients with type 2 diabetes mellitus. Clinical and experimental hypertension (New York, N.Y. : 1993). 2015:37(3):177-83. doi: 10.3109/10641963.2014.933964. Epub 2014 Jul 22
[PubMed PMID: 25050869]
[7]
Ostroumova OD, Kochetkov AI. [Effects of Amlodipine/Lisinopril Fixed-Dose Combination on Severity of Left Ventricular Hypertrophy and Parameters of Myocardial Stiffness in Patients With Hypertension]. Kardiologiia. 2016 Dec:56(11):27-37
[PubMed PMID: 28290816]
[8]
Lee EY, Park JK, Lee W, Kim YK, Park CS, Giles JT, Park JW, Shin K, Lee JS, Song YW, Lee EB. Head-to-head comparison of udenafil vs amlodipine in the treatment of secondary Raynaud's phenomenon: a double-blind, randomized, cross-over study. Rheumatology (Oxford, England). 2014 Apr:53(4):658-64. doi: 10.1093/rheumatology/ket417. Epub 2013 Dec 17
[PubMed PMID: 24352340]
Level 1 (high-level) evidence
[9]
Perna GP, Valle G, Cianfrone N, Luca GD, Amico C, Coli C. Amlodipine in ischaemic left ventricular dysfunction with mild to moderate heart failure. Clinical drug investigation. 1998:16(4):289-96
[PubMed PMID: 18370550]
[10]
Leonard L, Phillips WJ. Near-complete migraine prophylaxis with amlodipine: a case report. Journal of pain and symptom management. 2007 Dec:34(6):571-3
[PubMed PMID: 18053876]
Level 3 (low-level) evidence
[11]
Velayati A, Valerio MG, Shen M, Tariq S, Lanier GM, Aronow WS. Update on pulmonary arterial hypertension pharmacotherapy. Postgraduate medicine. 2016 Jun:128(5):460-73. doi: 10.1080/00325481.2016.1188664. Epub
[PubMed PMID: 27232660]
[12]
Writing Committee Members, Virani SS, Newby LK, Arnold SV, Bittner V, Brewer LC, Demeter SH, Dixon DL, Fearon WF, Hess B, Johnson HM, Kazi DS, Kolte D, Kumbhani DJ, LoFaso J, Mahtta D, Mark DB, Minissian M, Navar AM, Patel AR, Piano MR, Rodriguez F, Talbot AW, Taqueti VR, Thomas RJ, van Diepen S, Wiggins B, Williams MS. 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Journal of the American College of Cardiology. 2023 Aug 29:82(9):833-955. doi: 10.1016/j.jacc.2023.04.003. Epub 2023 Jul 20
[PubMed PMID: 37480922]
Level 1 (high-level) evidence
[13]
Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group. KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease. Kidney international. 2021 Mar:99(3S):S1-S87. doi: 10.1016/j.kint.2020.11.003. Epub
[PubMed PMID: 33637192]
Level 1 (high-level) evidence
[14]
Tang L, Gamal El-Din TM, Swanson TM, Pryde DC, Scheuer T, Zheng N, Catterall WA. Structural basis for inhibition of a voltage-gated Ca(2+) channel by Ca(2+) antagonist drugs. Nature. 2016 Sep 1:537(7618):117-121. doi: 10.1038/nature19102. Epub 2016 Aug 24
[PubMed PMID: 27556947]
[16]
Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, Ritz E, Atkins RC, Rohde R, Raz I, Collaborative Study Group. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. The New England journal of medicine. 2001 Sep 20:345(12):851-60
[PubMed PMID: 11565517]
[17]
Kuriyama S, Tomonari H, Tokudome G, Horiguchi M, Hayashi H, Kobayashi H, Ishikawa M, Hosoya T. Antiproteinuric effects of combined antihypertensive therapies in patients with overt type 2 diabetic nephropathy. Hypertension research : official journal of the Japanese Society of Hypertension. 2002 Nov:25(6):849-55
[PubMed PMID: 12484508]
[18]
Whiteley WN, Gupta AK, Godec T, Rostamian S, Whitehouse A, Mackay J, Sever PS. Long-Term Incidence of Stroke and Dementia in ASCOT. Stroke. 2021 Oct:52(10):3088-3096. doi: 10.1161/STROKEAHA.120.033489. Epub 2021 Jul 1
[PubMed PMID: 34192893]
[19]
Zhu Y, Wang F, Li Q, Zhu M, Du A, Tang W, Chen W. Amlodipine metabolism in human liver microsomes and roles of CYP3A4/5 in the dihydropyridine dehydrogenation. Drug metabolism and disposition: the biological fate of chemicals. 2014 Feb:42(2):245-9. doi: 10.1124/dmd.113.055400. Epub 2013 Dec 3
[PubMed PMID: 24301608]
[20]
Cataldi M, Celentano C, Bencivenga L, Arcopinto M, Resnati C, Manes A, Dodani L, Comnes L, Vander Stichele R, Kalra D, Rengo G, Giallauria F, Trama U, Ferrara N, Cittadini A, Taglialatela M. Identification of Drugs Acting as Perpetrators in Common Drug Interactions in a Cohort of Geriatric Patients from Southern Italy and Analysis of the Gene Polymorphisms That Affect Their Interacting Potential. Geriatrics (Basel, Switzerland). 2023 Aug 24:8(5):. doi: 10.3390/geriatrics8050084. Epub 2023 Aug 24
[PubMed PMID: 37736884]
[21]
Liang H, Zhang X, Ma Z, Sun Y, Shu C, Zhu Y, Zhang Y, Hu S, Fu X, Liu L. Association of CYP3A5 Gene Polymorphisms and Amlodipine-Induced Peripheral Edema in Chinese Han Patients with Essential Hypertension. Pharmacogenomics and personalized medicine. 2021:14():189-197. doi: 10.2147/PGPM.S291277. Epub 2021 Feb 2
[PubMed PMID: 33564260]
[22]
van Zwieten PA. Amlodipine: an overview of its pharmacodynamic and pharmacokinetic properties. Clinical cardiology. 1994 Sep:17(9 Suppl 3):III3-6
[PubMed PMID: 9156957]
Level 3 (low-level) evidence
[23]
Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, Ramirez A, Schlaich M, Stergiou GS, Tomaszewski M, Wainford RD, Williams B, Schutte AE. 2020 International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension (Dallas, Tex. : 1979). 2020 Jun:75(6):1334-1357. doi: 10.1161/HYPERTENSIONAHA.120.15026. Epub 2020 May 6
[PubMed PMID: 32370572]
Level 1 (high-level) evidence
[24]
Athyros VG, Katsiki N, Karagiannis A. Cardiovascular risk reduction with combination of anti-atherosclerotic medications in younger and older patients. Current medical research and opinion. 2013 Jul:29(7):791-2. doi: 10.1185/03007995.2013.805536. Epub 2013 May 29
[PubMed PMID: 23672630]
Level 3 (low-level) evidence
[25]
Curran MP. Amlodipine/Atorvastatin: a review of its use in the treatment of hypertension and dyslipidaemia and the prevention of cardiovascular disease. Drugs. 2010:70(2):191-213. doi: 10.2165/11204420-000000000-00000. Epub
[PubMed PMID: 20108992]
[26]
Teo KK, Pfeffer M, Mancia G, O'Donnell M, Dagenais G, Diaz R, Dans A, Liu L, Bosch J, Joseph P, Copland I, Jung H, Pogue J, Yusuf S, Aliskiren Prevention of Later Life Outcomes trial Investigators. Aliskiren alone or with other antihypertensives in the elderly with borderline and stage 1 hypertension: the APOLLO trial. European heart journal. 2014 Jul:35(26):1743-51. doi: 10.1093/eurheartj/ehu079. Epub 2014 Mar 9
[PubMed PMID: 24616335]
[27]
Zion AS, Izzo JL Jr. Combination therapy with aliskiren and amlodipine in hypertension: treatment rationale and clinical results. Expert review of cardiovascular therapy. 2011 Apr:9(4):421-7. doi: 10.1586/erc.11.23. Epub 2011 Mar 18
[PubMed PMID: 21417713]
[28]
Brook RD, Kaciroti N, Bakris G, Dahlöf B, Pitt B, Velazquez E, Weber M, Zappe DH, Hau T, Jamerson KA. Prior Medications and the Cardiovascular Benefits From Combination Angiotensin-Converting Enzyme Inhibition Plus Calcium Channel Blockade Among High-Risk Hypertensive Patients. Journal of the American Heart Association. 2018 Jan 4:7(1):. doi: 10.1161/JAHA.117.006940. Epub 2018 Jan 4
[PubMed PMID: 29301757]
[29]
Ruilope LM, SEVITENSION Study Investigators. Fixed-Combination Olmesartan/Amlodipine Was Superior to Perindopril + Amlodipine in Reducing Central Systolic Blood Pressure in Hypertensive Patients With Diabetes. Journal of clinical hypertension (Greenwich, Conn.). 2016 Jun:18(6):528-35. doi: 10.1111/jch.12673. Epub 2015 Sep 23
[PubMed PMID: 26395174]
[30]
Wang KL, Yu WC, Lu TM, Chen LC, Leu HB, Chiang CE. Amlodipine/valsartan fixed-dose combination treatment in the management of hypertension: A double-blind, randomized trial. Journal of the Chinese Medical Association : JCMA. 2020 Oct:83(10):900-905. doi: 10.1097/JCMA.0000000000000386. Epub
[PubMed PMID: 33009241]
Level 1 (high-level) evidence
[31]
Zhang ZY, Yu YL, Asayama K, Hansen TW, Maestre GE, Staessen JA. Starting Antihypertensive Drug Treatment With Combination Therapy: Controversies in Hypertension - Con Side of the Argument. Hypertension (Dallas, Tex. : 1979). 2021 Mar 3:77(3):788-798. doi: 10.1161/HYPERTENSIONAHA.120.12858. Epub 2021 Feb 10
[PubMed PMID: 33566687]
[32]
Calhoun DA, Lacourcière Y, Chiang YT, Glazer RD. Triple antihypertensive therapy with amlodipine, valsartan, and hydrochlorothiazide: a randomized clinical trial. Hypertension (Dallas, Tex. : 1979). 2009 Jul:54(1):32-9. doi: 10.1161/HYPERTENSIONAHA.109.131300. Epub 2009 May 26
[PubMed PMID: 19470877]
Level 1 (high-level) evidence
[33]
Tita AT, Szychowski JM, Boggess K, Dugoff L, Sibai B, Lawrence K, Hughes BL, Bell J, Aagaard K, Edwards RK, Gibson K, Haas DM, Plante L, Metz T, Casey B, Esplin S, Longo S, Hoffman M, Saade GR, Hoppe KK, Foroutan J, Tuuli M, Owens MY, Simhan HN, Frey H, Rosen T, Palatnik A, Baker S, August P, Reddy UM, Kinzler W, Su E, Krishna I, Nguyen N, Norton ME, Skupski D, El-Sayed YY, Ogunyemi D, Galis ZS, Harper L, Ambalavanan N, Geller NL, Oparil S, Cutter GR, Andrews WW, Chronic Hypertension and Pregnancy (CHAP) Trial Consortium. Treatment for Mild Chronic Hypertension during Pregnancy. The New England journal of medicine. 2022 May 12:386(19):1781-1792. doi: 10.1056/NEJMoa2201295. Epub 2022 Apr 2
[PubMed PMID: 35363951]
Level 3 (low-level) evidence
[34]
Society for Maternal-Fetal Medicine; Publications Committee. Electronic address: pubs@smfm.org. Society for Maternal-Fetal Medicine Statement: Antihypertensive therapy for mild chronic hypertension in pregnancy-The Chronic Hypertension and Pregnancy trial. American journal of obstetrics and gynecology. 2022 Aug:227(2):B24-B27. doi: 10.1016/j.ajog.2022.04.011. Epub 2022 Apr 19
[PubMed PMID: 35710594]
[35]
American College of Obstetricians and Gynecologists' Committee on Practice Bulletins—Obstetrics. ACOG Practice Bulletin No. 203: Chronic Hypertension in Pregnancy. Obstetrics and gynecology. 2019 Jan:133(1):e26-e50. doi: 10.1097/AOG.0000000000003020. Epub
[PubMed PMID: 30575676]
[36]
Malha L, August P. Safety of Antihypertensive Medications in Pregnancy: Living With Uncertainty. Journal of the American Heart Association. 2019 Aug 6:8(15):e013495. doi: 10.1161/JAHA.119.013495. Epub 2019 Jul 26
[PubMed PMID: 31345085]
[37]
Yin J, Mei Z, Shi S, Du P, Qin S. Nifedipine or amlodipine? The choice for hypertension during pregnancy: a systematic review and meta-analysis. Archives of gynecology and obstetrics. 2022 Dec:306(6):1891-1900. doi: 10.1007/s00404-022-06504-5. Epub 2022 Mar 19
[PubMed PMID: 35305140]
Level 2 (mid-level) evidence
[39]
Abman SH, Hansmann G, Archer SL, Ivy DD, Adatia I, Chung WK, Hanna BD, Rosenzweig EB, Raj JU, Cornfield D, Stenmark KR, Steinhorn R, Thébaud B, Fineman JR, Kuehne T, Feinstein JA, Friedberg MK, Earing M, Barst RJ, Keller RL, Kinsella JP, Mullen M, Deterding R, Kulik T, Mallory G, Humpl T, Wessel DL, American Heart Association Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation; Council on Clinical Cardiology; Council on Cardiovascular Disease in the Young; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Surgery and Anesthesia; and the American Thoracic Society. Pediatric Pulmonary Hypertension: Guidelines From the American Heart Association and American Thoracic Society. Circulation. 2015 Nov 24:132(21):2037-99. doi: 10.1161/CIR.0000000000000329. Epub 2015 Nov 3
[PubMed PMID: 26534956]
[40]
Vukadinović D, Scholz SS, Messerli FH, Weber MA, Williams B, Böhm M, Mahfoud F. Peripheral edema and headache associated with amlodipine treatment: a meta-analysis of randomized, placebo-controlled trials. Journal of hypertension. 2019 Oct:37(10):2093-2103. doi: 10.1097/HJH.0000000000002145. Epub
[PubMed PMID: 31107359]
Level 1 (high-level) evidence
[41]
. Calcium Channel Blockers. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. 2012:():
[PubMed PMID: 31643892]
[43]
Okumuş ÖF. Treatment of Gingival Growth Due to Amlodipine Use With a 445-nm Diode Laser: A Case Report. Cureus. 2022 Dec:14(12):e32592. doi: 10.7759/cureus.32592. Epub 2022 Dec 16
[PubMed PMID: 36660514]
Level 3 (low-level) evidence
[44]
Gandhi S, Fleet JL, Bailey DG, McArthur E, Wald R, Rehman F, Garg AX. Calcium-channel blocker-clarithromycin drug interactions and acute kidney injury. JAMA. 2013 Dec 18:310(23):2544-53. doi: 10.1001/jama.2013.282426. Epub
[PubMed PMID: 24346990]
[45]
Siriangkhawut M, Tansakul P, Uchaipichat V. Prevalence of potential drug interactions in Thai patients receiving simvastatin: The causality assessment of musculoskeletal adverse events induced by statin interaction. Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society. 2017 Sep:25(6):823-829. doi: 10.1016/j.jsps.2016.12.006. Epub 2016 Dec 23
[PubMed PMID: 28951665]
[46]
Savage RD, Visentin JD, Bronskill SE, Wang X, Gruneir A, Giannakeas V, Guan J, Lam K, Luke MJ, Read SH, Stall NM, Wu W, Zhu L, Rochon PA, McCarthy LM. Evaluation of a Common Prescribing Cascade of Calcium Channel Blockers and Diuretics in Older Adults With Hypertension. JAMA internal medicine. 2020 May 1:180(5):643-651. doi: 10.1001/jamainternmed.2019.7087. Epub
[PubMed PMID: 32091538]
[47]
Monge-Ortega OP, Domínguez-Ortega J, González-Muñoz M, Cabañas R, Lluch-Bernal M, Fiandor A, Bravo-Gallego LY, Quirce S. [Delayed allergic reaction to amlodipine with a positive lymphocyte transformation test]. Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993). 2017 Oct-Dec:64(4):505-508
[PubMed PMID: 29249113]
[48]
Agarwal MA, Flatt D, Khouzam RN. The potential detrimental effects of calcium channel blockers' overdose and current available management. Annals of translational medicine. 2018 Jan:6(1):16. doi: 10.21037/atm.2018.01.03. Epub
[PubMed PMID: 29404362]
[49]
de Vries RJ, van Veldhuisen DJ, Dunselman PH. Efficacy and safety of calcium channel blockers in heart failure: focus on recent trials with second-generation dihydropyridines. American heart journal. 2000 Feb:139(2 Pt 1):185-94
[PubMed PMID: 10650289]
[50]
Abernethy DR, Schwartz JB. Pharmacokinetics of calcium antagonists under development. Clinical pharmacokinetics. 1988 Jul:15(1):1-14
[PubMed PMID: 3042243]
[52]
Zuo XC, Zhou YN, Zhang BK, Yang GP, Cheng ZN, Yuan H, Ouyang DS, Liu SK, Barrett JS, Li PJ, Liu Z, Tan HY, Guo R, Zhou LY, Xie YL, Li ZJ, Li J, Wang CJ, Wang JL. Effect of CYP3A5*3 polymorphism on pharmacokinetic drug interaction between tacrolimus and amlodipine. Drug metabolism and pharmacokinetics. 2013:28(5):398-405
[PubMed PMID: 23438946]
[53]
St-Onge M, Dubé PA, Gosselin S, Guimont C, Godwin J, Archambault PM, Chauny JM, Frenette AJ, Darveau M, Le Sage N, Poitras J, Provencher J, Juurlink DN, Blais R. Treatment for calcium channel blocker poisoning: a systematic review. Clinical toxicology (Philadelphia, Pa.). 2014 Nov:52(9):926-44. doi: 10.3109/15563650.2014.965827. Epub 2014 Oct 6
[PubMed PMID: 25283255]
Level 1 (high-level) evidence
[54]
Omar S, Parris P, Gurke CR. Hemoadsorption Therapy for Calcium Channel Blocker Overdose: A Case Report. The Journal of emergency medicine. 2024 Apr:66(4):e463-e466. doi: 10.1016/j.jemermed.2023.11.022. Epub 2023 Dec 9
[PubMed PMID: 38461133]
Level 3 (low-level) evidence
[55]
Collier DJ, Taylor M, Godec T, Shiel J, James R, Chowdury Y, Ebano P, Monk V, Patel M, Pheby J, Pheby R, Foubister A, David C, Saxena M, Richardson L, Siddle J, Timlin G, Goldsmith P, Deeming N, Poulter NR, Gabe R, McManus RJ, Caulfield MJ. Personalized Antihypertensive Treatment Optimization With Smartphone-Enabled Remote Precision Dosing of Amlodipine During the COVID-19 Pandemic (PERSONAL-CovidBP Trial). Journal of the American Heart Association. 2024 Feb 20:13(4):e030749. doi: 10.1161/JAHA.123.030749. Epub 2024 Feb 7
[PubMed PMID: 38323513]
[56]
Santschi V, Wuerzner G, Pais B, Chiolero A, Schaller P, Cloutier L, Paradis G, Burnier M. Team-Based Care for Improving Hypertension Management: A Pragmatic Randomized Controlled Trial. Frontiers in cardiovascular medicine. 2021:8():760662. doi: 10.3389/fcvm.2021.760662. Epub 2021 Oct 25
[PubMed PMID: 34760950]
Level 1 (high-level) evidence